This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
NxStage Medical, Inc.
NxStage Medical, Inc., a leading innovator in the renal care industry, is headquartered in the United States. Founded in 1998, the company has made significant strides in transforming dialysis treatment through its advanced technologies. NxStage is renowned for its portable dialysis systems, particularly the System One, which offers patients greater flexibility and independence in managing their kidney disease. With a strong presence across North America and Europe, NxStage Medical focuses on home dialysis solutions, aiming to enhance patient quality of life. The company has achieved notable recognition for its commitment to patient-centric care and has established itself as a key player in the renal care market. Through continuous innovation and a dedication to improving treatment outcomes, NxStage Medical remains at the forefront of the industry.
DitchCarbon Score
How does NxStage Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NxStage Medical, Inc.'s score of 56 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
NxStage Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Fresenius Medical Care AG, which influences its climate commitments and emissions reporting. As part of this corporate family, NxStage Medical inherits sustainability initiatives and targets from Fresenius Medical Care AG, including those related to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). While specific reduction targets for NxStage Medical are not detailed, the overarching commitments from Fresenius Medical Care AG suggest a focus on reducing carbon emissions across their operations. This includes efforts to enhance sustainability practices and improve energy efficiency, although no absolute emissions figures or specific reduction achievements have been disclosed for NxStage Medical itself. As the company continues to align with its parent organisation's climate strategies, it is expected to contribute to broader industry efforts aimed at mitigating climate change impacts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
NxStage Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
